{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:58:30Z","timestamp":1792155510150,"version":"4.4.0"},"reference-count":78,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2014.00436","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T09:50:54Z","timestamp":1421229054000},"source":"Crossref","is-referenced-by-count":50,"title":["The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer\u00e2\u20ac\u2122s disease phenotype"],"prefix":"10.3389","volume":"8","author":[{"given":"Yash B.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pratic\u00c3\u00b2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/ars.2009.2668","article-title":"Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities","volume":"12","author":"Adibhatla","year":"2010","journal-title":"Antiox. Redox. Signal."},{"key":"B2","article-title":"Alzheimer\u00e2\u20ac\u2122s disease facts and figures","author":"Alzheimer\u00e2\u20ac\u2122s Association","year":"2014","journal-title":"Alzheimer\u00e2\u20ac\u2122s & Dementia 10."},{"key":"B3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0014-5793(93)80849-p","article-title":"Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5","volume":"336","author":"Baumann","year":"1993","journal-title":"FEBS Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/abbs\/gmt064","article-title":"5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy","volume":"45","author":"Bishayee","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1006\/nbdi.2000.0321","article-title":"Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1\u00e2\u20ac\u201c40 and Abeta1\u00e2\u20ac\u201c42 by human astrocytes","volume":"7","author":"Blasko","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1089\/ars.2012.5027","article-title":"Amyloid beta-peptide (1\u00e2\u20ac\u201c42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression","volume":"19","author":"Butterfield","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.2174\/15680266113139990141","article-title":"Clinical pharmacology of novel anti-Alzheimer disease modifying medications","volume":"12","author":"Caraci","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.neurobiolaging.2006.06.007","article-title":"The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old","volume":"28","author":"Chinnici","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-7-1","article-title":"Adeno-associated virus0mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice","volume":"7","author":"Chu","year":"2012a","journal-title":"Mol. Neurodegener."},{"key":"B10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ana.23642","article-title":"5-lipoxygenase gene transfer worsens memory, amyloid and tau brain pathologies in a mouse model of Alzheimer\u00e2\u20ac\u2122s disease","volume":"72","author":"Chu","year":"2012b","journal-title":"Ann. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.biopsych.2012.12.012","article-title":"The influence of 5-lipoxygenase on Alzheimer\u00e2\u20ac\u2122s disease-related tau pathology: in vivo and in vitro evidence","volume":"74","author":"Chu","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"174657","DOI":"10.1155\/2009\/174657","article-title":"The 5-lipoxygenase pathway as a common pathway for pathological brain and vascular aging","volume":"2009","author":"Chu","year":"2009","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.ajpath.2010.12.032","article-title":"Pharmacological blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer\u00e2\u20ac\u2122s disease transgenic mouse model involvement of gamma-secretase","volume":"178","author":"Chu","year":"2011a","journal-title":"Am. J. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ana.22234","article-title":"5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo","volume":"69","author":"Chu","year":"2011b","journal-title":"Ann. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1742-2094-9-127","article-title":"Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer\u00e2\u20ac\u2122s disease mouse model","volume":"9","author":"Chu","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.neurobiolaging.2012.12.009","article-title":"5-lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5","volume":"34","author":"Chu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/eb-2014-101741","article-title":"The value of vitamin E as a treatment for Alzheimer\u00e2\u20ac\u2122s disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs","volume":"19","author":"Corbett","year":"2014","journal-title":"Evid. Based Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.expneurol.2014.03.008","article-title":"Blocking leukotriene synthesis attenuates the pathophysiology of traumatic brain injury and associated cognitive deficits","volume":"256","author":"Corser-Jensen","year":"2014","journal-title":"Exp. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/s1734-1140(12)70914-3","article-title":"Evaulation of the antioxidative properties of lipoxygenase inhibitors","volume":"64","author":"Czapski","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"B20","first-page":"289","article-title":"Lipoxygenase inhibitors protect brain cortex macromolecules against oxidation evoked by nitrosative stress","volume":"48","author":"Czubowicz","year":"2010","journal-title":"Folia Neuropathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.febslet.2007.02.038","article-title":"Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution","volume":"581","author":"Dai","year":"2007","journal-title":"FEBS Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neurobiolaging.2003.12.026","article-title":"The microglial phagocytic role with specific plaque types in the Alzheimer\u00e2\u20ac\u2122s disease brain","volume":"25","author":"D\u00e2\u20ac\u2122Andrea","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1196\/annals.1379.012","article-title":"Imaging and CSF studies in the preclinical diagnosis of Alzheimer\u00e2\u20ac\u2122s disease","volume":"1097","author":"de Leon","year":"2007","journal-title":"Ann. N Y Acad. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.neurobiolaging.2014.05.016","article-title":"Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer\u00e2\u20ac\u2122s disease mice","volume":"35","author":"Di Meco","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u00e2\u20ac\u2122s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2013.282834","article-title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial","volume":"311","author":"Dysken","year":"2014","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1096\/fj.07-9131.com","article-title":"5-lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer\u00e2\u20ac\u2122s disease","volume":"22","author":"Firuzi","year":"2008","journal-title":"FASEB J."},{"key":"B78","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.biopsych.2013.04.009","article-title":"5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer\u00e2\u20ac\u2122s disease","volume":"74","author":"Giannopoulos","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/mp.2013.23","article-title":"Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer\u00e2\u20ac\u2122s disease","volume":"19","author":"Giannopoulos","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0006-8993(94)91586-5","article-title":"Nordihydroguaiaretic acid protects hippocampal neurons against amyloid \u00ce\u00b2-peptide toxicity and attenuates free radical and calcium accumulation","volume":"15","author":"Goodman","year":"1994","journal-title":"Brain Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","article-title":"Glycogen synthase kinase-3 induces Alzheimer\u00e2\u20ac\u2122s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase","volume":"147","author":"Hanger","year":"1992","journal-title":"Neurosci. Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000351096","article-title":"MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice","volume":"13","author":"Hawkes","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u00e2\u20ac\u2122s disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u00e2\u20ac\u2122s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1369\/jhc.2008.951855","article-title":"Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer\u00e2\u20ac\u2122s disease","volume":"56","author":"Ikonomovic","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2174\/156802611795860942","article-title":"\u00ce\u00b3-secretase inhibitors and modulators for the treatment of Alzheimer\u00e2\u20ac\u2122s disease: disappointments and hopes","volume":"11","author":"Imbimbo","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mad.2013.02.008","article-title":"Markers of oxidant stress that are clinically relevant in aging and age-related disease","volume":"134","author":"Jacob","year":"2013","journal-title":"Mech. Aging Dev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/mp.2013.171","article-title":"The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogenesis of major neurocognitive disorders","volume":"19","author":"Jo","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1042\/BST0390886","article-title":"Assessing the contribution of inflammation in models of Alzheimer\u00e2\u20ac\u2122s disease","volume":"39","author":"Johnston","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"B40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u00e2\u20ac\u2122s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u00e2\u20ac\u2122s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neurobiolaging.2013.11.016","article-title":"Modulation of lipopolysaccharide-induced memory insult, gamma-secretase and neuroinflammation in triple transgenic mice by 5-lipoxygenase","volume":"35","author":"Joshi","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4168\/aair.2014.6.4.288","article-title":"Cysteinyl leukotrienes and their receptors: emerging concepts","volume":"6","author":"Kanaoka","year":"2014","journal-title":"Allergy Asthma Immunol. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e60921","DOI":"10.1371\/journal.pone.0060921","article-title":"Functional impairment of microglia coincides with beta-amyloid deposition in mice with Alzheimer-like pathology","volume":"8","author":"Krabbe","year":"2013","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1471-4159.1996.66010147.x","article-title":"Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling","volume":"66","author":"Lammers","year":"1996","journal-title":"J. Neurochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer\u00e2\u20ac\u2122s disease: implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1212\/WNL.42.2.447","article-title":"Anti-inflammatory agents as a therapeutic approach to Alzheimer\u00e2\u20ac\u2122s disease","volume":"42","author":"McGeer","year":"1992","journal-title":"Neurology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1212\/wnl.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer\u00e2\u20ac\u2122s disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u00e2\u20ac\u2122s disease","volume":"1822","author":"Mecocci","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B49","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-131843","article-title":"Tau oligomers and fibrils induce activation of microglial cells","volume":"37","author":"Morales","year":"2013","journal-title":"J. Alzheimer Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","article-title":"Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \u00e2\u20ac\u0153do count\u00e2\u20ac\u009d when staging disease severity","volume":"66","author":"Nelson","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1074\/jbc.m507892200","article-title":"Temporal profile of amyloid-beta(Abeta) oligomerization in an in vivo model of Alzheimer\u00e2\u20ac\u2122s disease: a link between Abeta and tau pathology","volume":"281","author":"Oddo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1471-4159.2011.07187.x","article-title":"Low-n oligomers as therapeutic targets of Alzheimer\u00e2\u20ac\u2122s disease","volume":"117","author":"Ono","year":"2011","journal-title":"J. Neurochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","article-title":"Distribution of active glycogen synthase kinase 3\u00ce\u00b2 (GSK-3\u00ce\u00b2) in brans staged for Alzheimer disease neurofibrillary changes","volume":"58","author":"Pei","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2174\/156720511796391908","article-title":"Nutritional approaches to modulate oxidative stress in Alzheimer\u00e2\u20ac\u2122s disease","volume":"8","author":"Pocernich","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1176\/appi.neuropsych.13.2.304","article-title":"5-lipoxygenase (5-LOX) promoter polymorphisms in patients with early-onset and late-onset Alzheimer\u00e2\u20ac\u2122s disease","volume":"13","author":"Qu","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbrc.2010.02.173","article-title":"Regulation of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis","volume":"396","author":"R\u00c3\u00a5dmark","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell Signal."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/nejm199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u00e2\u20ac\u2122s disease. The Alzheimer\u00e2\u20ac\u2122s disease cooperative study","volume":"336","author":"Sano","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/jci102150","article-title":"The cerebral blood flow in male subjects as measured by the nitrous oxide technique. Normal values for blood flow, oxygen utilization, glucose utilization and peripheral resistance with observations on the effect of tilting and anxiety","volume":"28","author":"Scheinberg","year":"1949","journal-title":"J. Clin. Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0304-3940(00)01037-5","article-title":"Regional distribution of cortical microglial parallels that of neurofibriallary tangles in Alzheimer\u00e2\u20ac\u2122s disease","volume":"285","author":"Sheffield","year":"2000","journal-title":"Neurosci. Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005072-199703000-00007","article-title":"Glial-neuronal interactions in Alzheimer\u00e2\u20ac\u2122s disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages","volume":"56","author":"Sheng","year":"1997a","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004010050664","article-title":"Neuritic plaque evolution in Alzheimer\u00e2\u20ac\u2122s disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms","volume":"94","author":"Sheng","year":"1997b","journal-title":"Acta Neuropathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer\u00e2\u20ac\u2122s disease amyoid beta peptide","volume":"8","author":"Smith","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"B65","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/wnl.48.3.626","article-title":"Risk of Alzheimer\u00e2\u20ac\u2122s disease and duration of NSAID use","volume":"48","author":"Stewart","year":"1997","journal-title":"Neurology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1179\/1351000213Y.0000000052","article-title":"Oxidative stress in Alzheimer\u00e2\u20ac\u2122s disease: primary villain or physiological by-product","volume":"18","author":"Sutherland","year":"2013","journal-title":"Redox Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\u00e2\u20ac\u2122s disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J. Alzheimer Dis."},{"key":"B68","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1096\/fasebj.12.6.439","article-title":"Aging-associated upregulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability","volume":"12","author":"Uz","year":"1998","journal-title":"FASEB J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.1523\/JNEUROSCI.5183-12.2013","article-title":"Modulation of 5-lipoxygenase proteotoxicity and Alzheimer\u00e2\u20ac\u2122s disease","volume":"33","author":"Valera","year":"2013","journal-title":"J. Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1210\/en.2011-0145","article-title":"Glucocorticoids facilitate astrocytic amyloid-\u00ce\u00b2 peptide deposition by increased expression of APP and BACE1 and decreasing the expression of amyloid-\u00ce\u00b2-degrading proteases","volume":"152","author":"Wang","year":"2011a","journal-title":"Endocrinology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.neuint.2013.01.002","article-title":"Leukotriene D4 induces amyloid-beta generation via CysLT(1)R-mediated NF-kappaB pathways in primary neurons","volume":"62","author":"Wang","year":"2013","journal-title":"Neurochem. Int."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1248\/yakushi.131.1843","article-title":"Overexpression of 5-lipoxygenase increases the neuronal vulnerability of PC12 cells to A\u00ce\u00b242","volume":"131","author":"Wang","year":"2011b","journal-title":"Yakugaku Zasshi"},{"key":"B73","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1742-2094-10-84","article-title":"Down\u00e2\u20ac\u2122s syndrome, neuroinflammation and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e59586","DOI":"10.1371\/journal.pone.0059586","article-title":"Neuroinflammation an neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer\u00e2\u20ac\u2122s disease","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One"},{"key":"B75","first-page":"325","article-title":"In vitro and in vivo oxidative stress associated with Alzheimer\u00e2\u20ac\u2122s amyloid beta-peptide (1\u00e2\u20ac\u201c42)","volume":"20","author":"Yatin","year":"1999","journal-title":"Neurobiol. Aging"},{"key":"B76","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1742-2094-9-47","article-title":"Who fans the flames of Alzheimer\u00e2\u20ac\u2122s disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways","volume":"9","author":"Zilka","year":"2012","journal-title":"J. Neuroinflammation"}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T14:30:50Z","timestamp":1566225050000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fncel.2014.00436\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,14]]},"references-count":78,"URL":"https:\/\/doi.org\/10.3389\/fncel.2014.00436","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,14]]}}}